FASN and prostate cancer: As a consequence of the loss of the tumor suppressor gene PTEN, prostate cancer cells undergo metabolic reprogramming, resulting in fatty acid synthase (FAS) overexpression, the production of fatty acids and cholesterol, and the proliferation of prostate cancer cells that are malignant.